Funding for this research was provided by:
Japan Society for the Promotion of Science (20H00411, 16H02544)
Article History
Received: 16 November 2021
Accepted: 22 January 2022
First Online: 31 January 2022
Declarations
:
: Dengue patient sera were obtained from the Centre of Pharmaceutical and Medical Technology, National Research and Innovation Agency, Jakarta, Indonesia. Serum collection protocols were reviewed and approved by the Health Research Ethics Committee-University of Indonesia and Cipto Mangunkusumo Hospital (HREC-FMUI/CMH) (approval no. KET-1358/UN2.F1/ETIK/PPM.00.02/2020). Animal experimental protocols were reviewed and approved by the Research Ethical Committee of the Faculty of Medicine, Universitas Indonesia (No. KET-721/UN2.F1/ETIK/PPM.00.02/2021). All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
: Not applicable.
: The authors declare that they have no competing interests.